The following reader question came in response to the column “Critical Guidance for Complying With Anesthesia Infection Control Rules,” which features insight from Clifford Gevirtz, MD, an ...

The Food & Drug Administration approved a multi-dose vial presentation of Audenz, a vaccine made by Summit-based Seqirus for individuals six months and older against bird flu, also known as influenza ...

The approval expands Amneal’s injectables portfolio with an essential medicine used in hospitals for emergency and perioperative care. Epinephrine is a non-selective alpha and beta adrenergic agonist.

BRIDGEWATER, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) (Nasdaq: AMRX) today announced that the U.S. Food and Drug Administration (FDA) has ...

Credit: Getty Images. Audenz is an inactivated cell-based influenza vaccine that contains MF59, a proprietary adjuvant. The Food and Drug Administration (FDA) has approved a multidose vial ...

Marshall M. Baker, MS, FACMPE, president of the Accreditation Association for Ambulatory Health Care, offers advice on the appropriate use of multi-dose vials. AAAHC has been a SIPC steering committee ...

Natco launches Semaglutide vials in India after patent expiry Natco's vials are 70% cheaper than pen devices, boosting access Dr Reddy's and Emcure shares rise as Semaglutide patent expires Shares of ...

(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced that the U.S. FDA has approved its Epinephrine injection USP, 1 mg/mL, in both single-dose and multi-dose for use in U.S. hospitals.